Daehan Nupharm Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	202,401	202,187	204,223	197,957	166,586
Other Revenue	-	-0	-	-0	-0
Revenue	202,401	202,187	204,223	197,957	166,586
Revenue Growth (YoY)	0.11%	-1.00%	3.16%	18.83%	11.58%
Cost of Revenue	111,347	106,710	111,986	109,403	84,994
Gross Profit	91,054	95,477	92,236	88,554	81,593
Selling, General & Admin	69,968	70,585	63,237	56,799	50,779
Research & Development	7,499	1,329	4,106	2,284	2,156
Amortization of Goodwill & Intangibles	100.14	102.28	98.91	100.22	74.06
Other Operating Expenses	836.37	1,027	4,394	744.91	680.51
Operating Expenses	79,329	76,812	73,377	60,605	55,210
Operating Income	11,725	18,665	18,859	27,949	26,383
Interest Expense	-1,670	-1,760	-1,762	-1,254	-907.33
Interest & Investment Income	252.68	397.17	1,084	405.63	233.54
Earnings From Equity Investments	-253.77	-466.76	-142.53	-26.5	-
Currency Exchange Gain (Loss)	5	-113.09	-193.13	-230.6	-216.93
Other Non Operating Income (Expenses)	703.77	372.02	289.66	9,275	-1,347
EBT Excluding Unusual Items	10,762	17,094	18,136	36,119	24,145
Gain (Loss) on Sale of Investments	4,511	1,281	2,547	-1,608	-564.19
Gain (Loss) on Sale of Assets	-289.84	-0.53	-0.53	9.51	-0.36
Pretax Income	14,983	18,375	20,683	34,520	23,580
Income Tax Expense	-274.54	2,907	8,141	10,203	7,886
Net Income	15,258	15,468	12,542	24,317	15,694
Net Income to Common	15,258	15,468	12,542	24,317	15,694
Net Income Growth	-1.36%	23.33%	-48.42%	54.95%	-
Shares Outstanding (Basic)	-	14	14	14	14
Shares Outstanding (Diluted)	-	14	14	14	14
EPS (Basic)	-	1102.08	893.60	1732.58	1118.17
EPS (Diluted)	-	1102.08	893.60	1732.58	1118.17
EPS Growth	-	23.33%	-48.42%	54.95%	-
Free Cash Flow	-45,175	-14,083	2,830	10,822	5,958
Free Cash Flow Per Share	-	-1003.40	201.62	771.04	424.51
Gross Margin	44.99%	47.22%	45.16%	44.73%	48.98%
Operating Margin	5.79%	9.23%	9.23%	14.12%	15.84%
Profit Margin	7.54%	7.65%	6.14%	12.28%	9.42%
Free Cash Flow Margin	-22.32%	-6.97%	1.39%	5.47%	3.58%
EBITDA	16,027	22,763	22,340	31,177	29,712
EBITDA Margin	7.92%	11.26%	10.94%	15.75%	17.84%
D&A For EBITDA	4,302	4,098	3,481	3,228	3,330
EBIT	11,725	18,665	18,859	27,949	26,383
EBIT Margin	5.79%	9.23%	9.23%	14.12%	15.84%
Effective Tax Rate	-	15.82%	39.36%	29.56%	33.45%
Advertising Expenses	2,473	3,069	3,654	3,456	4,184

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.